DE BERARDINIS, PIERGIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 2.452
NA - Nord America 1.146
EU - Europa 419
SA - Sud America 418
AF - Africa 37
OC - Oceania 2
Totale 4.474
Nazione #
US - Stati Uniti d'America 1.082
SG - Singapore 938
CN - Cina 672
BR - Brasile 334
VN - Vietnam 209
HK - Hong Kong 203
KR - Corea 160
FR - Francia 113
IT - Italia 80
JP - Giappone 65
IN - India 56
FI - Finlandia 43
GB - Regno Unito 37
DE - Germania 36
AR - Argentina 32
NL - Olanda 28
CA - Canada 26
IL - Israele 20
BD - Bangladesh 19
ID - Indonesia 19
MX - Messico 17
RU - Federazione Russa 14
PL - Polonia 13
TR - Turchia 13
ZA - Sudafrica 13
CO - Colombia 11
EC - Ecuador 10
PY - Paraguay 10
IQ - Iraq 9
PK - Pakistan 9
MA - Marocco 8
SA - Arabia Saudita 8
SE - Svezia 8
AT - Austria 7
ES - Italia 7
UY - Uruguay 6
UZ - Uzbekistan 6
CL - Cile 5
PH - Filippine 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
RO - Romania 4
UA - Ucraina 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
TJ - Tagikistan 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IE - Irlanda 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
Totale 4.474
Città #
Singapore 573
Hefei 357
Santa Clara 307
San Jose 210
Hong Kong 201
Seoul 159
Beijing 88
Lauterbourg 86
Ashburn 78
Los Angeles 71
Ho Chi Minh City 68
Hanoi 52
Tokyo 42
Dallas 41
São Paulo 33
Helsinki 32
New York 29
Minamishinagawa 19
Frankfurt am Main 15
Orem 15
Rio de Janeiro 15
Marigliano 14
Bengaluru 13
Buffalo 13
Da Nang 12
Lappeenranta 11
Rome 10
Avellino 9
Chennai 9
Montreal 9
Atlanta 8
Chicago 8
Denver 8
Haiphong 8
Warsaw 8
Manchester 7
Phoenix 7
Stockholm 7
Afragola 6
Belo Horizonte 6
Brasília 6
Council Bluffs 6
Dhaka 6
London 6
Ninh Bình 6
Nuremberg 6
Santo André 6
Tashkent 6
Amsterdam 5
Biên Hòa 5
Brooklyn 5
Curitiba 5
Düsseldorf 5
Falkenstein 5
Guarulhos 5
Guayaquil 5
Johannesburg 5
Montevideo 5
Praia Grande 5
Ankara 4
Asunción 4
Baghdad 4
Bogotá 4
Bologna 4
Bắc Ninh 4
Campinas 4
Hyderabad 4
Jakarta 4
Jeddah 4
Lahore 4
Nairobi 4
Osaka 4
Salvador 4
Santiago 4
São Bernardo do Campo 4
Toronto 4
Amman 3
An Giang Province 3
Athens 3
Boardman 3
Buenos Aires 3
Campos dos Goytacazes 3
Cape Town 3
City of London 3
Dushanbe 3
Garanhuns 3
Guangzhou 3
Houston 3
Jackson 3
Jundiaí 3
Kunming 3
Maceió 3
Mexico City 3
Miami 3
Milan 3
Naples 3
New Orleans 3
Poplar 3
Quito 3
Quixadá 3
Totale 2.907
Nome #
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 111
Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell. 111
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy 88
T cell receptors 88
T Cell Receptor (Tcr) Repertoire in Coeliac Disease (Cd): Conserved Junctional Sequences in the Untreated Mucosa. 88
HIV Vaccination: A Roadmap among Advancements and Concerns. 86
T Cell Receptor (Tcr) Repertoire in Coeliac Disease (Cd): Conserved Junctional Sequences in the Untreated Mucosa. 83
Varianti del recettore delle cellule T e loro uso nella terapia tumorale 81
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [F-18]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 78
Multimeric proteins able to induce antibody response against the beta-amyloid and use thereof 74
Immunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the marine diatom Thalassiosira weissflogii: Inspiration for a novel synthetic toll-like receptor 4 agonist 74
Review HIV Vaccination: A Roadmap among Advancements and Concerns 72
Filamentous bacteriophage fd as an antigen delivery system in vaccination 71
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants. 70
Alum and Squalene-Oil-in-Water Emulsion enhance the titer and avidity of Anti-Ab antibodies induced by Multimeric Protein Antigen (i-11)E2, preserving the IgG1-skewed isotype distribution 70
Design of cassette vectors permitting cloning of all types of human TCR variable alpha and beta regions 68
Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay 67
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 64
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 62
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant 61
Analysis of the Consolidation Phase of Immunological Memory within the IgG Response to a B Cell Epitope Displayed on a Filamentous Bacteriophage 60
Generation and characterization of two human alpha /beta T cell clones recognizing autologous breast tumor cells through a HLAand TCR/CD3 independent pathway 58
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 57
Arming filamentous bacteriophage, aNature-made nanoparticles, for new vaccine and immunotherapeutic strategies 56
Distinct Antigen Delivery Systems Induce Dendritic Cells' Divergent Transcriptional Response: New Insights from a Comparative and Reproducible Computational Analysis. 55
Multimeric proteins able to induce antibody response against the beta-amyloid and use thereof 54
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 54
Searching for new vaccine vectors: E2 protein from B. stearothermophilus PDH complex. 53
An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy 53
Recombinant antigens to establish a model of autoimmunity in mice 51
ImmuNapoli 2019 51
Chitosan decorated cobalt zinc ferrite nanoferrofluid composites for potential cancer hyperthermia therapy: anti-cancer activity, genotoxicity, and immunotoxicity evaluation 50
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies 50
PHAGE CONJUGATES AND USES THEREOF 49
Recombinant filamentous bacteriophages encapsulated in biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses 47
PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based vaccine: in vitro and in silico-supported approach 46
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 45
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 45
Cell loaded hydrogel containing Ag-doped bioactive glass-ceramic nanoparticles as skin substitute: Antibacterial properties, immune response, and scarless cutaneous wound regeneration 43
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 43
A multimeric immunogen for the induction of immune memory to beta-amyloid 42
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 39
Editorial : Targeted Antigen Delivery: bridging innate and adaptive immunity 38
Filamentous bacteriophage: an antigen and gene delivery system 37
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 37
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 37
Phage display of a CTL epitope elicits a long term in vivo cytotoxic response 35
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 34
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFN³ production by CD4+ T cells 33
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. 33
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses 33
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 33
Epitope context and reshaping of activated T helper cell repertoire 32
E2 display as a novel vaccine approach to induce HIV-1 neutralizing antibodies. 32
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform. 32
Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR 9 Expression 32
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 32
Antigen delivery by using filamentous bacteriophage FD or a macromolecular scaffold derived from a multienzyme complex 32
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 31
How the interval between prime and boost injection affects the immune response in a computational model of the immune system 31
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 31
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. 30
Design and characterizationof mimotope of the HIV-1 gp120 Bridging Sheet 30
In vitro immunization with a recombinant antigen carrying the HIV-1 RT248-262 determinant inserted at different locations results in altered TCRVB region usage. 30
Modulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensions. 29
Phage display of a CTL epitope elicits a long-term in vivo cytotoxic response. 29
New recombinant vaccine based on filamentous bacteriophage fd particles targeting DC 29
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 29
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 29
Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages. 29
Anti-beta amyloid antibodies induced by a multimeric protein antigen formulated in alum, squalene or without adjuvant. 28
Multimeric proteins able to induce an antibody response to beta-amyloid and use thereof. 28
Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex. 28
Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses 28
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo 28
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. 28
ImmuNapoli 2016 27
E2 display as a novel vaccine approach to induce HIV-1 neutralizing antibodies 27
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 27
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 27
Novel Antigen Display System To Elicit Anti- V3 Region/Membrane Proximal External Regjion HIV - 1 Neutralizing Antibodies 26
The lag time before the secondary response to antigen: insights from a mathematical interpretation of experimental datas 26
Autoimmunità e Tolleranza 26
Long-Term culture and T cell receptor analysis of T cell clones isolated from a patient with adenosine deaminase deficiency and type 1 diabetes 26
Cellular and molecular mechanisms of vaccination by bacteriophages. 26
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 26
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 26
Novel antigen delivery systems. 26
Comparative analysis of innovative vaccine formulations based on the use of procaryotic display systems. 25
Identification of a new subset of cells exhibiting dendritic phenotypes in patients affected by breast proliferative disorders. 25
Delivery strategies for novel vaccine formulations 25
Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: Effect on T helper cell repertoire selection 25
Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge 25
Immunogenicity of B and T epitopes displayed on bacteriophage fd 24
Novel Antigen Display System To Elicit Anti-V3 Region/Membrane Proximal External Region HIV-1 Neutralizing Antibodies 23
The majority of gliadin specific T cells clones from the coeliac small intestinal mucosa produce both ginterferon and Il4 22
Construction of new antigen delivery systems for innovative vaccine formulations 22
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 22
Massive-scale RNA-seq analysis of non ribosomal transcriptome in human Trisomy 21. 22
null 20
Totale 4.331
Categoria #
all - tutte 13.441
article - articoli 9.102
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 272
Totale 22.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202463 0 0 0 0 0 0 0 1 0 0 51 11
2024/20251.643 9 8 125 48 318 44 7 155 52 48 442 387
2025/20262.853 181 331 299 501 449 156 375 109 143 178 131 0
Totale 4.559